# Fibrocell Science, Inc.

Fibrocell Science, Inc. is a company headquartered in Exton, PA, United States.

## Company overview

- **Legal name:** Fibrocell Science, Inc.
- **Former names in filing history:** ISOLAGEN INC (2002-04-22 to 2009-09-14); AMERICAN FINANCIAL HOLDING INC /DE (1996-11-22 to 2001-08-22)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Exton, PA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000357097

## About

Fibrocell Science, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000357097, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-27, it reported annual revenue of USD 0; net income of USD -10,277,000; total assets of USD 15,758,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$10.3M (USD -10,277,000)
- **Total assets:** $15.8M (USD 15,758,000)
- **Cash and equivalents:** $14.4M (USD 14,430,000)
- **Operating cash flow:** -$12.7M (USD -12,717,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$16.2M (USD -16,240,000)
- **Total assets:** $19.4M (USD 19,411,000)
- **Cash and equivalents:** $17.4M (USD 17,417,000)
- **Operating cash flow:** -$17.0M (USD -17,037,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $355,000 (USD 355,000)
- **Net income:** -$15.3M (USD -15,292,000)
- **Total assets:** $19.6M (USD 19,582,000)
- **Cash and equivalents:** $17.5M (USD 17,515,000)
- **Operating cash flow:** -$29.4M (USD -29,390,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $492,000 (USD 492,000)
- **Net income:** -$34.5M (USD -34,453,000)
- **Total assets:** $36.7M (USD 36,712,000)
- **Cash and equivalents:** $29.3M (USD 29,268,000)
- **Operating cash flow:** -$24.1M (USD -24,106,000)

## Recent SEC filings

- Form 8-K — filed 2019-12-13 — period 2019-12-13 — FORM 8-K
- Form 8-K — filed 2019-12-10 — period 2019-12-10 — FORM 8-K
- Form 8-K — filed 2019-11-22 — period 2019-11-21 — FORM 8-K
- Form 10-Q — filed 2019-11-14 — period 2019-09-30 — 10-Q
- Form SC 13G — filed 2019-09-25
- Form 8-K — filed 2019-09-13 — period 2019-09-12 — 8-K
- Form 8-K — filed 2019-09-12 — period 2019-09-12 — 8-K
- Form 8-K — filed 2019-08-22 — period 2019-08-18 — 8-K
- Form 8-K — filed 2019-08-15 — period 2019-08-14 — 8-K
- Form 10-Q — filed 2019-08-14 — period 2019-06-30 — 10-Q
- Form 8-K — filed 2019-07-02 — period 2019-07-02 — 8-K
- Form 8-K — filed 2019-06-14 — period 2019-06-12 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/fibrocell-science-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology